Alberto Guijosa

11PUBLICATIONS
41CO-AUTHORS
Medical virologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Oct 28, 2026
Impact of initial dosing and subsequent dose reduction of zanubrutinib in patients with Waldenström macroglobulinemia.

|Mar 15, 2026
Final Report of a Phase II Study of Ibrutinib and Venetoclax in Previously Untreated Waldenström Macroglobulinemia.

Jorge J Castillo, Andrew R Branagan, Alberto Guijosa

|Mar 07, 2026
Venetoclax or Pirtobrutinib in Relapsed/Refractory Waldenström Macroglobulinemia: Clinical and Molecular Predictors and Sequencing Implications.

Alberto Guijosa, Nickolas Tsakamaklis, Margaret Kobs

|Oct 21, 2025
Familial clusters and clinical features, complications, and outcomes in 1000 patients with Waldenström macroglobulinemia.

Andres Ramirez-Gamero, Nicholas Tsakmaklis, Zachary R Hunter

|Jul 17, 2025
Long-term follow-up of venetoclax monotherapy in previously treated patients with Waldenström macroglobulinemia.

Jorge J Castillo, Alberto Guijosa, John N Allan

|Apr 03, 2025
Current and emerging treatment perspectives for adults with Waldenström macroglobulinemia.

Alberto Guijosa, Shayna Sarosiek, Jorge J Castillo

Pageof 2

Frequent Collaborators

6 joint publications

Steven P Treon

6 joint publications

Zachary R Hunter

6 joint publications

Jorge J Castillo

4 joint publications

Maria Luisa Guerrera